Introduction
High-throughput genomic technologies such as genome-wide mRNA expression arrays (microarrays) and single nucleotide polymorphisms (SNPs) produce thousands of measurements for each sample. A common goal in a microarray experiment is to identify genes that are differentially expressed between two or more experimental conditions. 1 A typical statistical approach is to perform an appropriate statistical significance test for each gene (eg, gene-by-gene unpaired t-test or two-sample Wilcoxon test) followed by a multiple comparison procedure (MCP), controlling either for the overall rate of false positives or of false discoveries. Many different MCP methods have been proposed for high dimensional data sets, and a comprehensive review of these methods can be found in Dudoit and colleagues. 2 The false discovery rate (FDR) method 3 is perhaps the most popularly used MCP method in microarrays. 4 Storey and colleagues proposed a Q value as an extension of FDR. 5 The Q value is similar to the well known P value. The Q value is a measure of significance in terms of the FDR, while the P value is a measure of significance in terms of the false positive rate (FPR). The Q value is implemented in the Significance Analysis of Microarrays (SAM), a popularly used free software for the microarray analysis (http://www-stat.stanford.edu/∼tibs/SAM/) developed by Tibshirani's group at Stanford University.
Until recently MCP methods focused mostly on controlling the number of false positives, but when a difference between two groups is of a modest magnitude, the existing methods can result in a poor power to detect genes that are truly differentially expressed. 6 To improve a power of selecting truly differentially expressed genes, some authors proposed a hybrid approach such as evaluating FDR in conjunction with secondary measures, for example, the FNR or fold change. Norris and colleagues proposed a "balance probability analysis" 6 which provides a biologist with a method for interpreting results in the context of the total number of truly differentially expressed genes, FDRs and FNRs for the list of genes reaching any significance threshold. Rosenfeld suggested a modification of the classical t-test, 7 which is specifically designed to enhance the sensitivity of detection of differentially expressed genes. Rosenfeld proposed a test statistic called a "bio-weight", which is defined as the product of the absolute fold change and the negative decimal logarithm of the t-test P value. In this paper, we propose a "balancing factor score" (BFS ) method which combines the P values from the conventional significance test and any other informative factors that may increase the sensitivity of identifying differentially expressed genes (eg, fold change or P value from another microarray experiment). Under certain circumstances, the proposed BFS method can substantially improve the detection of truly differentially expressed genes by reducing the FNR while keeping a reasonable level of FDR.
Material and methods

Motivating example
The BFS method was motivated by an actual microarray experiment conducted by a biomedical scientist from the Oregon National Primate Research Center at the Oregon Health and Science University. The experiment examined the effect of age and gender on gene expression of hippocampus among rhesus macaques. The experiment was performed as a 2 × 3 factorial design with a total of six groups defined by two gender levels (male, female) and three age levels (adult, middle-aged, old). There were approximately four animals per group with a total of 24 animals. The microarray experiment was carried out by the OHSU Gene Microarray Shared Resource Affymetrix Microarray Core using the Rhesus Macaque GeneChip. After appropriate pre-processing and normalization, a two-way analysis of variance was fitted to each gene separately, and the FDR adjustment was applied to each factor (gender, age, gender by age interaction) independently. After the FDR adjustment, there were no genes that met a FDR P value  0.05 for the interaction effect and only a handful of genes that met the FDR P value  0.05 for gender and age main effects. Because the cost of obtaining additional samples was prohibitive, we explored alternative methods of identifying a set of differentially expressed genes and for assessing the FNR of the FDR-adjusted P value criterion. Although our motivation came from one particular study, we expect that similar situations arise elsewhere. In some experiments, the cost of obtaining biologic samples is very high, and it is not always possible to increase the sample size. In addition, many microarray experiments are performed primarily as a screening procedure with identified genes being evaluated by another experimental platform (such as quantitative real time transcription -polymerase chain reaction [qRT-PCR]). In those circumstances, it may be acceptable to have a slightly higher FDR in exchange for a larger pool of potentially differentially expressed genes. These considerations prompted us to investigate a hybrid approach which is based on both P values and other factors that may help identify a set of differentially expressed genes.
Notations and definitions
To simplify, we will focus on a problem of identifying a set of differentially expressed genes between two groups (eg, normal vs disease), where one may apply a simple unpaired t-test or Wilcoxon rank sum test to each gene individually. Table 1 summarizes the resulting test outcomes and the definition of key concepts used in this paper. Specifically we focus on the FNR and FDR.
Illustration using simulated data
We simulated a microarray data set with the following conditions: (1) 52,865 genes; (2) 30 samples (15 samples per group) and (3) 10% of genes (N 1 = 5,287) truly differentially expressed with the mean difference of 0.748 standard deviation unit [ie, t-statistics of 2.05 (t 0.025, 28 )]. In each gene, the FDR P value threshold of 5% is used to identify differentially expressed genes. As expected, the FDR is approximately 5%, Open Access Bioinformatics 2010:2
Balancing false discoveries and false negatives in gene microarrays Dovepress submit your manuscript | www.dovepress.com Dovepress that is, 69 genes are identified as differentially expressed with only four being false positives. Surprisingly, however, 5,222 genes are false negative, ie, falsely declared as not differentially expressed, and the FNR is 0.99. The FDR-adjusted P value criterion sacrifices too many false negatives in order to control the number of false positives. If the raw P values without any MCP adjustments are used, the FNR is 0.49, but the FDR is 0.47, and thus too high to be acceptable, leading to costly follow-up experiments with very few conformed genes. Figure 1 displays the volcano plot, ie, a scatter plot of observed mean differences in the x axis vs -log 10 (FDR P values) in the y axis. The red dots represent true differentially expressed genes, and the vertical line represents the FDR-adjusted P value threshold value of 0.05. In a typical microarray study, genes above the vertical line are declared as differentially expressed genes. As seen in Figure 1 , most of the false negative genes are associated with a larger fold change value. An alternative method that incorporates the fold change information may lead to a better detection of differentially expressed genes, and may balance between the FDR and FNR.
BFS method
A balancing factor is any informative factor that may help identify differentially expressed genes in addition to the standard p values from statistical significance testing. A BFS is defined as a quantitative measure of a balancing factor ranging from 0 (strong differential expression) to 1 (no differential expression), analogous to the p value. A BFS can be created by first transforming it to the standardized z score and computing the standard normal probability. For example, consider a fold change (FC) defined as: sign(∆)*2 |∆| , where ∆ is a mean difference of normalized log signal values between the experimental and control groups. A fold change of -2 implies twofold downregulation, while a fold change of 2 means twofold upregulation in the experimental group compared with the control group. A fold change can be used as a balancing factor, and the BFS can be created by using the standardized normal probability as:
For each gene, a BFS statistic (T BFS ) can be computed as:
where p is the unadjusted P value for the conventional test, λ 0 is the weight for the unadjusted P value, and λ i is a weight for the ith balancing factor so that λ λ
is always between 0 and 1, and one can consider it as a modified P value. We will then apply the FDR method to T BFS to calculate the FDR-adjusted T BFS value, denoted by FDR(T BFS ). A gene is then declared as differentially expressed 
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if FDR(T BFS ) is less than α, specified cut-off value (usually 0.05), and otherwise declared not differentially expressed.
Note that if λ 0 = 1 and λ I = 0 for all i  0, then this is equivalent to the FDR-adjusted P value criterion. A choice of balancing factors is not unique, but there are obvious candidates including a fold change, P value from the previous microarray experiment, P value from the published study or publicly available data, or P value representing biologic relevance (eg, a likelihood of a particular gene belonging to a pathway of interest).
If BFS i follows beta distributions for the ith test, λ 0 is the probability of there being no difference, and λ 1 is the P value of being truly differentially expressed in ith test, then the BFS method has the same structural form as the mixture model proposed by Allison and colleagues. 8 The BFS method can be extended to identify a set of differentially expressed genes when the microarray experiment is performed at multiple times or using different platforms such as DNA methylation. In a special case when a balancing factor is a P value from another, independently conducted experiment, the BFS test statistic can be expressed as: T BFS = λ 0 p 0 + λ 1 p 1 , where p 0 is the P value from the current experiment and p 1 is the P value from another study. In this case, we can determine the actual distribution and cut-off value for the BFS method that provides a specified error rate (see Appendix 1).
Results
A simulation study is conducted to evaluate the performance of the BFS method when a fold change is considered as a balancing factor. A total of 500 simulated data sets are generated under the following conditions: (1) Two groups; (2) 15 samples per group; (3) 10,000 genes (N) on each microarray; (4) the proportion of truly differentially expressed genes (N 1 ) is either 5% or 10%; (5) among truly differentially expressed genes, the fold change varies from 1.5, 2.0 and 3.0, and (6) the expression values are normally distributed. The following procedure is applied to each simulated data set:
where SD |FC| is the standard deviation of the absolute fold change values 2. Calculate the BFS using T BFS = λ 0 p + λ 1 BFS, where p is a P value from two-sample t-test 3. Calculate Benjamini Hochberg FDR-adjusted T BFS , denoted as FDR(T BFS ) 4. If FDR(T BFS ) is smaller than the pre-determined threshold value, typically 0.05, then declare the gene as differentially expressed.
Simulation results are summarized in terms of empirical FDR and FNR. We evaluate FDR (T BFS ) for various values of λ 1 between 0 to 1. If λ 1 = 0, this is equivalent to the standard FDR-adjusted P value criterion. The performance of the BFS method is shown as a function of the weight λ 1 and is compared with the FDR-adjusted P value criterion as well as the criterion based on unadjusted P values. Table 2 shows the performance of the BFS method when the proportion of truly differentially expressed genes is 10% with a relatively large fold change (FC = 3.0). The FNR of the FDR-adjusted P value criterion is 0.12, whereas the FNR of the BFS method is consistently smaller for all λ 1 (0.07-0.11) while maintaining a comparable FDR level. In this simulation scenario, regardless of a choice of λ 1 , the BFS method not only identifies more true positive genes but also identifies fewer false positives than typically used selection methods. Table 3 shows the simulation results for the other extreme when the proportion of truly differentially expressed genes is small (5%) with a moderate change (FC = 1.5).
In this setting, the FDR-adjusted P value criterion fails to identify true differentially expressed genes. It only detects 0.54 genes on average. If the unadjusted P value criterion is used, on average, 647 genes are declared to be differentially expressed, while 476 genes are false positives. Even in this extreme case, the BFS method provides a reasonable number of genes (0-85 genes depending on λ 1 ) that can be pursued further for confirmation. Figures 2a and 2b illustrate the FDR (2a) and FNR (2b), respectively, as a function of λ 1 , when 10% of genes are truly differentially expressed. The BFS method appears to make the most impact on FNR when the fold change is moderate (FC = 2.0) as shown in Figure 2b . Figure 2c demonstrates that the BFS method is superior not only for reducing false negatives but also false positives when compared with the FDR-adjusted P value criterion in some conditions. Tables 4 and 5 summarize additional simulations results on FDR and FNR.
Discussion
Genome-wide mRNA expression profiling using microarrays is widely available in biomedical research. However, the cost of a microarray experiment including sample generation, preparation, assays and chips can be prohibitive, and many microarray experiments are performed using modest number of biologic samples and are often inadequately powered. Therefore it is not surprising that we have to balance our risk of false positives and false negatives when identifying a set of differentially expressed genes. We have shown that the BFS method incorporating additional informative factors such as a fold change in addition to P values from statistical significance testing can improve the overall detection rate by reducing the number of false negatives while keeping the number of false positives at a reasonable level. The BFS method can be extended easily to incorporate other balancing factors, such as P values from the previous experiment or another study. In this paper, we focused on the FNR and FDR. Genovese and Wasserman introduced the false nondiscovery rate (FNDR) 9 and proposed methods that incorporate both FDR and FNDR. The FNDR may be a conceptually better measure because it complements the FDR. Genovese and Wasserman suggested using 1-π as a risk function to compare the performance of various multiple testing procedures, 5 where π = 1 -FDR -FNDR. This is equivalent to the concept of power introduced by Sarkar, 10 reflecting how well a multiple comparison procedure performs in terms of the overall correct decisions. However in most studies, the number of genes that are declared as differentially expressed is much smaller, and the FNDR contributes very little relative to the FDR. Hence, the FNDR may not contribute significantly to the risk function. 
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We applied the BFS method to the microarray experiment described previously as the motivating example. The BFS method did not offer a larger set of differentially expressed genes than the set identified by the FDR P value  0.05 criterion. For example, there were 24 genes that met FDR P value  0.05 for gender difference. When the BFS method is applied, the number of genes actually decreased to 12. This was due to the fact that the average fold change was 1.05 with only 18 genes showing more than a twofold change. Based on these analyses, we concluded that age and gender effects on gene expression were very subtle in hippocampus.
In some cases, there may exist a unique λ 1 that satisfies FPR(λ 1 ) = FNR(λ 1 ); however, our simulation results show that λ 1 does not always exist, as seen in Figure 2 . When the magnitude of differential expression is relatively small (eg, FC = 1.5), the FDR-adjusted P value criterion fails to identify differentially expressed genes (see Table 3 ). However, the BFS method offers at least a handful of genes that biomedical researchers can pursue and then perform a confirmation experiment. In this situation, the choice of λ 1 should depend on the resources available to the researcher for follow-up experiments and her/his willingness to take a risk for potential false positive genes. When the magnitude of differential expression is large (eg, FC = 3.0), a medium range of λ 1 reduces the number of false negatives as well as false positives. In the real experiment we have no idea regarding the proportion of truly differentially expressed genes or the magnitude of differential expression, therefore an analytical and/or empirical approach for finding an optimal choice of λ 1 would be helpful in the future. Open Access Bioinformatics is an international, peer-reviewed, open access journal publishing original research, reports, reviews and commentaries on all areas of bioinformatics. The manuscript management system is completely online and includes a very quick and fair peer-review system. Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.
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